Divi's Laboratories532488Pharmaceuticals, CDMO
Viewer asked which is better between Divi's Labs and Syngene in CDMO space; analyst preferred Divi's
By ScoutQuest · · 1 min read
Heard on business television between 14:02:27 - 14:05:27 IST.
- Avinash Ghorakshakar said Divi's is an established player in CDMO space
- Said company has gradually scaled up business over last 5-10 years
- Noted stock has corrected but Q1 numbers seen, Q2 expected slightly better
- Advised investors can stay invested for 12-18 months for reasonable returns
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Divis Laboratories
Board meeting on November 7 to approve unaudited results for Q2 and H1 of FY 2026-27
22 Oct 2026
Divi's Lab in focus after Eli Lilly's anti-diabetes drug, for which Divi's manufactures an intermediate, received positive response in Europe
19 Oct 2026
Source: Live TV News Channel · 23 Oct 2026
The call above is Avinash Ghorakshakar, Avinash Mentor Research Services's, reported here as they made it. Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.